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Pocket Guide for Clinicians
For ages 5-11 years
Comparative Doses of Generic and Brand Name Inhaled Corticosteroids
Reassess uncontrolled asthma every 2 to 6 weeks until good control is achieved.
Use lowest dose needed to keep asthma well controlled. Consider step down if controlled for > 3 months
This brief clinical guide for the management
of asthma is based on the Expert Panel
Report 3 and 4 (draft) and GINA 2020 report
and other current asthma research.
Use caution in assessing asthma symptoms.
Many patients do not report "normal"
symptoms and may ration inhaler use even
when symptomatic. Consider using an
approach like the following, and do not rely
on frequency of SABA use as a conclusive
measure of asthma control.
In general over the past 1 to 4 weeks:
1. How many days a week do you have any
symptoms of recurrent coughing,
wheezing, chest tightness/pain or
repetitive throat clearing?
2. How many nights a week do you wake
up from your asthma symptoms?
3. Has asthma limited your activity in any
way lately?
4. What medication are you currently taking
for your asthma and how do you take it?
5. How many times did you need to use
your rescue inhaler for symptoms?
6. Do you always take your rescue inhaler
when you have symptoms or do you
wait?
COVID-19 guidance: avoid nebulizers or
spirometry when possible to prevent
aerosolizing virus.
Mammen, J.R. (2021) University of Rhode Island. Adapted from Expert Panel Report (EPR) 3, EPR4 (2020 update) guidelines for management of asthma and the Global Initiative
for Asthma (GINA) 2020 Pocket Guide for Asthma Management and Prevention. This brief guide is a general summary and does not represent the entirety of the EPR3, EPR4 or
GINA guidelines. For additional details please refer to the full guidelines. Version date: 2/19/2021
Help us help you: For additional
updated copies of this guide, scan























































































































































Key points for patient and family education and self-management training:
1. Symptoms of asthma indicate "swelling" (inflammation) in lungs. Chronic inflammation causes "scarring"
over time (remodeling). Emphasize symptoms > twice a week can lead to permanent scarring in the lungs.
2. Review medication types - Rescue and Control. Emphasize only control medication can "stop the scarring"
and protect long term lung functioning. Control medication takes days to weeks to work. Explain that
decreased swelling = fewer symptoms = less need for/dependence on SABA over time.
3. Emphasize that asthma inhalers only work if taken correctly - "Get it in and keep it in." It is critical to explain,
model, and require return demonstration of inhaler technique over multiple visits. Use spacer for all ages.
4. Help establish an easy to follow routine: Keep inhalers in high visibility/access locations (ex. with toothbrush).














Management of Persistent Asthma in Individuals Ages 5 to 11 Years Old
Consult with asthma specialist if Step 4 or higher is needed.
Reassess uncontrolled asthma every 2 to 6 weeks until good control is achieved.
Classifying Asthma Severity in Individuals Ages 5 to 11 Years Old
Assess severity BEFORE start of controller therapy based on symptoms, OR estimated based on level of stepwise therapy PLUS current level of control.
ICS = inhaled corticosteroid (ICS+LABA indicates combined/concomitant use of both medications
LABA = long acting beta agonist
LAMA = long acting muscarinic agonist
LTRA = leukotriene receptor agonist
OCS = oral systemic corticosteroid
SABA = short acting beta agonist
Assess and document severity and control at every visit. Control corresponds with highest level of current symptoms in any box.








2-6 puffs albuterol or 1
nebulizer; up to 3




Days: once a day ≤2 days/wk
Wake up: <2/month
Activity: no limitations
PEF or FEV1: > 80%
SABA: ≤2 times/wk
Symptoms:
>2 days/wk OR >2x ≤2 days/wk
Wake up: 3 - 4/month
Activity: minor limitations
PEF or FEV1: > 80%
SABA: >2 times/wk
Symptoms:
Days: most days/everyday (but not throughout the day)
Wake up: >1/week but not nightly; *(≥2/week is VPC)
Activity: some limitations
PEF or FEV1: 60 - 80%
SABA: Daily
Symptoms:
Days: throughout the day
Wake up: often nightly
Activity: extremely limited
PEF or FEV1: < 60%
SABA: several times daily
Intermittent Mild Persistent Moderate Persistent Severe Persistent
Preferred EPR4 & GINA:
• Daily low-dose ICS
and PRN SABA
Alternative EPR4 & GINA:
• Daily LTRA and PRN
SABA
Alternative (GINA):
• As needed low-dose
ICS taken when
SABA used







ICS and PRN SABA
• Daily low-dose ICS
and LTRA and PRN
SABA












OR add LTRA or LAMA
Preferred EPR4:
• High dose ICS+LABA
and PRN SABA






• Daily high-dose ICS
and LTRA and PRN
SABA
• For other options:
see guidelines
FDA issued Boxed Warning for









Copyright J.R. Mammen 2021- Free for non-commercial distribution. Adapted from Expert Panel Report (EPR) 3, EPR4 (draft 2020 update) guidelines for management of asthma and the Global Initiative for Asthma (GINA) 2020 Pocket Guide for Asthma Management and Prevention
oral/systemic steroid use > 1 x year Very poorly controlled (VPC)Not well controlled (NWC)
*SMART - Single Maintenance and Reliever Therapy (currently off label in U.S.): Preferred for all patients at step 3 to 4;
SMART is combined ICS + formoterol (LABA) given daily for control PLUS as needed for symptoms (up to 8 total puffs per day for ages 5 to 11 years old).
Version date: 2/19/2021
